2026 HCPR32 Medication for Alcohol Use Disorder (MAUD) for Patients with Alcohol Use Disorder

Measure Title: Medication for Alcohol Use Disorder (MAUD) for Patients with Alcohol Use Disorder

Description: Percentage of patients diagnosed with Alcohol Use Disorder who were prescribed a Medication for Alcohol Use Disorder (MAUD)

Denominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional with a diagnosis of alcohol use disorder (transferred, eloped, AMA, or expired patients excluded)

Numerator: Patients that were prescribed a Medication for Alcohol Use Disorder (MAUD): Naltrexone, Acamprosate, Disulfiram, or other FDA-approved MAUD.

Denominator Exclusions:

None

Denomiator Exceptions: Documented patient refusal, medication allergy or specific medication contraindication. – Naltrexone: opioid dependence, acute opioid withdrawal, acute hepatitis, liver failure. – Acamprosate: renal failure, or GFT<=30. – Disulfiram: coronary artery disease, heart failure, psychosis; patients receiving metronidazole, paraldehyde, or alcohol-containing preparations.

National Quality Forum (NQF) number, if applicable

N/A

Care setting(s)

Hospital Inpatient; Hospital; Emergency Department and Services; Post-Acute Care; Ambulatory Care: Hospital; Ambulatory Care: Urgent Care; Hospital Outpatient

Telehealth, if applicable
Yes

Number of performance rates required for measures
1

Traditional vs. inverse measure
Traditional

Proportional, continuous variable, and/or ratio measure indicator
Proportional

Risk adjustment, if applicable
No

Submission pathway
Traditional MIPS